Resources & Evidence Contact us

136 Results:

Sort By:

Human milk-based fortifiers cut mortality rate by 50% in preterm infants, independent study shows

Type: Press Releases

Topic(s): Clinical Studies Mortality

Study shows exclusive human milk diet benefits term infants post-gastroschisis repair; Data to be presented at ESPGHAN 2024 meeting

Type: Press Releases

Topic(s): Clinical Studies Conferences and Events

Pediatric Academic Societies Meeting includes symposium on cost-effectiveness of implementing exclusive human milk-based nutrition for premature infants

Type: Press Releases

Topic(s): Conferences and Events

Novel research illuminates breast milk’s unique contribution to COVID-19 defense in infants

Type: Press Releases

Topic(s): Conferences and Events

Real-world data on human milk-based fortification reveals limitations of protocol designs of two RCTs

Type: Press Releases

Topic(s): Company

Prolacta's human milk-based nutrition has touched the lives of 100,000 Premature and Critically Ill Infants Globally

Type: Press Releases

Topic(s): Company

Prolacta Bioscience recognizes advances in preterm care during NICU awareness month

Type: Press Releases

Topic(s): Company

Prolacta Bioscience applauds Ohio legislature for supporting Medicaid reimbursement for donor human milk-derived products

Type: Press Releases

Topic(s): Legislative

New study shows Prolacta’s human milk-based nutritional fortifiers save hospital NICUs up to $3.4M annually

Type: Press Releases

Topic(s): Bronchopulmonary Dysplasia (BPD) Clinical Studies on Prolact/Humavant CR Cost Savings / Cost Effectiveness Length of hospital stay Necrotizing Entercolitis (NEC)

Not finding the reference you’re looking for?

Use our main search field or email us at info@prolacta.com